if take over happens then the big pharma takes on risk of all the other products in the pipeline, hypothetically if the big pharma takes over then would they not want to wait until all or most of the products are at the end of their evolution before FDA approval? OR takeover once one or products have been officially approved?
if take over happens then the big pharma takes on risk of all...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.110(11.1%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.11 | 95.5¢ | $15.75M | 15.06M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 79396 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 60351 | 4 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.10 |
Change
0.110 ( 10.8 %) |
||||
| Open | High | Low | Volume | ||
| 96.5¢ | $1.11 | 95.5¢ | 2700730 | ||
| Last updated 15.59pm 01/05/2024 ? | |||||
| MSB (ASX) Chart |